GARDASIL 9 60 ug/.5mL

GARDASIL 9 60 ug/0.5mL is a 9-valent HPV vaccine designed to help prevent certain HPV-related conditions. This recombinant vaccine is administered via intramuscular injection and is available in single-dose vials.

GARDASIL 9 60 ug/0.5mL is primarily used to help prevent infections caused by nine types of human papillomavirus (HPV). These types are associated with various health conditions, including cervical, vaginal, vulvar, and anal cancers, as well as genital warts. The vaccine is intended for use in individuals to help reduce the risk of these HPV-related conditions.

Common effects of GARDASIL 9 60 ug/0.5mL may include pain, swelling, or redness at the injection site. Some individuals might experience headaches, fatigue, or mild fever following vaccination. These effects are generally mild and temporary.

GARDASIL 9 60 ug/0.5mL should be stored as directed to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Always follow the advice of a healthcare professional regarding vaccination.

GARDASIL 9 60 ug/0.5mL may interact with certain medications or health conditions. It is advisable to discuss any current medications or health issues with a healthcare provider before receiving the vaccine. Specific interactions should be evaluated by a medical professional.